1. Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro

   • Heather J. Parry
   • Robert C. Rees

   Original articles Pages: 355 - 360

2. Comparative efficiencies of bispecific F(ab′γ)₂ and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fcγ receptors

   • John Greenman
   • Nancy Hogg
   • Martin Glennie

   Original articles Pages: 361 - 369

3. Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor α

   • Koji Adachi
   • Paul Belser
   • Dorothee Herlyn

   Original articles Pages: 370 - 376

4. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen

   • Kelly K. Hunt
   • Masahiko Shibata
   • Donald L. Morton

   Original articles Pages: 377 - 382

5. Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour

   • Giulia Acerbis
   • Loredana Cleris
   • Franca Formelli

   Original articles Pages: 383 - 388

6. Effect ofNocardia rubra cell-wall skeleton on cancer prevention in humans

   • Michio Yamakido
   • Shinichi Ishioka
   • Yukio Nishimoto

   Original articles Pages: 389 - 392

7. Role of interferon γ and tumour necrosis factor α in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line

   • Arjan A. van de Loosdrecht
   • Gert J. Ossenkoppele
   • Mart M. A. C. Langenhuijsen

   Original articles Pages: 393 - 398

8. Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance

   • Susan C. Wright
   • Albert W. Tam
   • Poornima Kumar

   Original articles Pages: 399 - 406

9. Anti-(human LFA-1) monoclonal antibodies bind P815 murine tumour cells

   • Marie-José Palisson
   • Anne Altemeyer
   • Pierre Bischoff

   Original articles Pages: 407 - 413

10. Ability of recombinant interferon γ in vitro to restore the defective polymorphonuclear-cell-but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes

    • Giuliana De Sanctis
    • Vincenzo Bottari
    • Luigi Fontana

    Original articles Pages: 414 - 418

11. Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A

    • Yoshihiko Hayashi
    • Dave S. B. Hoon
    • Donald L. Morton

    Short communication Pages: 419 - 423

12. Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancer

    • Darcy V. Spicer
    • Ann Kelley
    • Malcolm S. Mitchell

    Short communication Pages: 424 - 426